Received Aug 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | yN2X2 | — |
8-month-old patient accidentally received a dose of Kinrix; 8-month-old patient accidentally received a dose of Kinrix as their third IPV and DTaP series; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-month-old female patient who received DTPa-IPV (Kinrix) (batch number yN2X2, expiry date 01-OCT-2026) for prophylaxis. On 14-JUL-2025, the patient received Kinrix. On 14-JUL-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 8-month-old patient accidentally received a dose of Kinrix) and inappropriate schedule of vaccine administered (Verbatim: 8-month-old patient accidentally received a dose of Kinrix as their third IPV and DTaP series). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-JUL-2025 A nurse called in to report that an 8-month-old patient accidentally received a dose of Kinrix as their third IPV and DTaP series, which led to an inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. They stated the first two doses were with Pediarix. The vaccine administration facility was the same as primary reporter.